To study the nature of genes that are involved during apoptotic death of hepatocyte precursor cells, we identified a novel gene termed praja-1 (encoding a RING finger Protein involved in cell Apoptosis, Juxtaposition and Architecture). Inhibition of praja-1 results in dramatic apoptosis of hepatocytes utilizing embryonic liver explant cultures. PRAJA-1 is a unique protein with RING-H2, zinc finger domain and a proline rich C-terminal region that is down-regulated during apoptosis induced in 32Dcl3 cells that are strictly dependent on IL-3 for growth and apoptose when deprived of IL-3 from the medium. The experiments proposed are aimed at understanding the role of praja-1 in the apoptosis, differentiation and transformation of hepatocytes.
The aims are: 1. To carry out a detailed biochemical characterization of the protein encoded by praja-1 to determine its sub-cellular localization, post-translational modification patterns, and possible association with other signal transducing proteins via its RING-H2 domain and thus its mechanism of action. 2. To test (i) whether praja-1 expression is increased in v-abl, and bcr-abl-transformed 32Dcl3 cells. Transformation of 32Dcl3 cells with v-abl, and bcr-abl enables them to grow in the absence of IL-3, yet remain susceptible to apoptosis induced by xenobiotic agents. Therefore we will also test whether apoptotic stimuli produced by different xenobiotic agents such as calphostin C, methotrexate etoposide and mitomycin. C reduce the expression of praja-1 (ii) whether ectopic over-expression of praja-1 renders 32Dcl3 cells less sensitive to apoptotic death induced by the above xenobiotic agents. (iii) PRAJA-1 is also down-regulated when embryonic liver explants are induced to terminally differentiate into hepatocytes in the presence of Hepatocyte Growth Factor (HGF), Insulin, and IL-6. In this aim, we propose to study the effects of transgenic expression of praja on embryonic liver explant cultures, and hepatoma cell lines such as PLC/PRF/5 cells for cell growth, differentiation and apoptosis. 3. To study the functional and developmental role of praja-1 by generating mice lacking praja-1 expression by targeted mutagenesis. We have constructed a vector target praja-1 deletion by disrupting exon 2 and the RING-H2 domain. Electroporation into ES cells produced 148 clones. Further analysis by Southern blotting, using an 894-base-pair-pair (bp) 5' praja-1 probe has revealed five homologous recombinant events. These clones bearing the disrupted praja-1 gene will bee used to generate praja-1 +/- mice, and subsequent mating to generate praja-1-/- mice.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Serrano, Jose
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Temple University
Schools of Medicine
United States
Zip Code
Shin, Joshua; Mishra, Viveka; Glasgow, Eric et al. (2017) PRAJA is overexpressed in glioblastoma and contributes to neural precursor development. Genes Cancer 8:640-649
Yao, Zhixing; Mishra, Lopa (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8:1691-8
Lin, L; Amin, R; Gallicano, G I et al. (2009) The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 28:961-72
Baek, Hye Jung; Lim, Sung Chul; Kitisin, Krit et al. (2008) Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis. Hepatology 48:1128-37
He, Aiwu Ruth; Mendelson, Jonathan; Blake, Tiffany et al. (2008) Stem cells in gastrointestinal cancers. Dis Markers 24:217-22
Yun, Chohee; Mendelson, Jonathan; Blake, Tiffany et al. (2008) TGF-beta signaling in neuronal stem cells. Dis Markers 24:251-5
Glasgow, Eric; Mishra, Lopa (2008) Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer 15:59-72
Tang, Yi; Kitisin, Krit; Jogunoori, Wilma et al. (2008) Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A 105:2445-50
Kitisin, K; Ganesan, N; Tang, Y et al. (2007) Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene 26:7103-10
Katuri, V; Tang, Y; Li, C et al. (2006) Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression. Oncogene 25:1871-86

Showing the most recent 10 out of 25 publications